Next Article in Journal
Energy Absorption of Aluminium Extrusions Filled with Cellular Materials Under Axial Crushing: Study of the Interaction Effect
Next Article in Special Issue
Hyperlipidemic Rabbit Models for Anti-Atherosclerotic Drug Development
Previous Article in Journal
Practical Model for Metamaterials in Wireless Power Transfer Systems
Previous Article in Special Issue
Rabbit as an Aging Model in Reproduction: Advanced Maternal Age Alters GLO1 Expression in the Endometrium at the Time of Implantation
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Applied Sciences
Volume 10
Issue 23
10.3390/app10238508
applsci-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

The Creation of a Multiallele Knockout Genotype in Rabbit Using CRISPR/Cas9 and Its Application in Translational Medicine

by
Tímea Pintér
1,2,
Miklós Geiszt
3,
Gábor L. Petheő
3,
Máté Mihálffy
3,
Gabriella Skoda
1,
Nándor Lipták
1,
Andrea Kerekes
1,
Zsuzsanna Bősze
1,
László Hiripi
1,2,* and
Lilla Bodrogi
1,*
1
Rabbit Genome Biology and Biomodel Group, Department of Animal Biotechnology, National Agricultural Research and Innovation Center, Szent-Györgyi Albert str. 4, 2100 Gödöllő, Hungary
2
Institute of Genetics and Biotechnology, Szent István University, Páter Károly str. 1, 2100 Gödöllő, Hungary
3
Department of Physiology, Faculty of Medicine, Semmelweis University, Üllői str. 26, 1085 Budapest, Hungary
*
Authors to whom correspondence should be addressed.
Appl. Sci. 2020, 10(23), 8508; https://0-doi-org.brum.beds.ac.uk/10.3390/app10238508
Submission received: 29 October 2020 / Revised: 24 November 2020 / Accepted: 25 November 2020 / Published: 28 November 2020
(This article belongs to the Special Issue Rabbit Models for Translational Medicine)
Browse Figures
Versions Notes

Abstract

:
Nonrodent animal models have recently become more valuable in preclinical studies. The limitation of nonrodent animal models is that they must demonstrate relatively reliable and predictable responses in addition to representing complex etiologies of a genetically diverse patient population. In our study, we applied CRISPR/Cas9 technology to produce transgenic rabbits. This approach can be useful for creating genetically divergent and homogeneous populations for studies in translational medicine. NADPH oxidase 4 (NOX4) is a promising therapeutic target, as it is linked to several pathologies including stroke, atherosclerosis, and lung and kidney fibrosis. NOX4 knockout (KO) rabbit lines were created in order to study the in vivo effects resulting from a lack of NOX4 protein and loss of gene function. One of the knockout founders was a germline multiallelic knockout male. Its offspring segregated into three distinct NOX4 knockout and a wild-type lines. Mosaicism is a relatively frequent phenomenon in rabbit transgenesis. Our results point to the possible application of mosaicism in preclinical studies. However, careful planning and evaluation of results are necessary. The predicted off-target sites were studied as well, and no signs of off-target events were detected.

1. Introduction

Since the creation of the first genetic knockout rabbits with the CRISPR/Cas9 method in 2014 [1], the number of publications on CRISPR/Cas9-modified rabbits has increased, touching on a wide array of topics such as improving meat quality [2], altering fur color [3], studying the metabolic features [4,5], modeling human diseases [6], producing recombinant proteins [7], and improving the methodology [8,9,10]. Compared to rodents, rabbits are phylogenetically more closely related to humans, and many physiological processes, such as lipid and carbohydrate metabolism [11,12], disease progression in the case of atherosclerosis [13,14], cardiac diseases [15], and obesity [16,17], are more similar to those in humans. In addition, because of their similar anatomy and bigger size, experimentation is more achievable with rabbits, and they are hence considered to be a better subject for studies in translational medicine [18].
CRISPR/Cas9 technology in animal transgenesis has undergone great improvements in recent years. Prior to the employment of this technique, it was a big challenge to knockout a gene in rabbits because of the lack of suitable embryonic stem cells [19,20,21] and the low efficiency and difficulties associated with rabbit somatic cell nuclear transfer [22]. Now, with the almost completely sequenced rabbit genome and expertise available, CRISPR/Cas9 is a relatively robust technology that can be used to knockout almost any gene in rabbits. Knocking out a gene with CRISPR/Cas9 is based on targeted cutting of double-stranded DNA and the cells’ own mechanism of DNA damage repair by nonhomologous end joining (NHEJ), resulting in indels at the target site that usually result an early stop codon that leads to fast degradation of mRNA [23,24].
In order to reduce the number of experimental animals and test mutations rapidly, embryo culturing and testing for mutations at the blastocyst stage are suitable alternatives. In mice, in vitro cultured preimplantation stage blastocysts have been appropriate for testing the fidelity of CRISPR/Cas9-mediated genome editing [25].
Concerns remain about the unwanted off-target effects of CRISPR/Cas9 technology. However, modified Cas9 enzymes with higher specificity and improved algorithms that allow researchers to choose the most suitable guide RNA (gRNA) provide a stable background to overcome this challenge [26,27].
Genetic mosaicism of founder animals is a known phenomenon in CRISPR/Cas9-mediated gene editing, as summarized in the review of Mehravar et al. [28]. CRISPR/Cas9 is directly injected into the cytoplasm or pronuclei of fertilized oocytes. As zygotes develop, cells continuously divide, and the CRISPR-directed Cas9 enzyme is able to cut the targeted locus at further stages of development. As a consequence, somatic and/or germline mosaicism develops in the founder animals [28]. Mosaicism was investigated in mice, for example, as described by the authors of [29,30], following the injection of CRISPR/Cas9 components targeting the tyrosinase gene locus, revealing the occurrence of diverse allelic modifications of the tyrosinase gene and also affecting the germline of the founder animals. However, in most cases, the germline cells of the founder animal carry only one type of modified allele. Interestingly, mosaicism in founder transgenic rabbits appears more frequently than in mice. Early rabbit embryos undergo a rapid series of cell divisions and can reach the four-cell stage within half a day [31]. In humans, rodents, and livestock animals, this takes 30–40 h after fertilization. The early timing of differentiation can explain the high mosaicism rates during rabbit transgenesis [32]. Despite the high rate of mosaicism in transgenic rabbits, to our best knowledge, a germline multiallelic knockout rabbit has not previously been described.
NADPH oxidase 4 (NOX4) is an important and widely expressed member of the NADPH oxidase family that is responsible for the production of reactive oxygen species (ROS). NOX4 is an important regulatory protein for many cellular processes, including cell division and differentiation [33], apoptosis [34], host defense [35], and oxygen sensing [36], in addition to contributing to gene regulatory pathways [37,38]. In mammals, including rabbits, humans, and rodents, its main expression site is the kidney [39], and it is also expressed in many other tissues, such as lung, liver, and brain. NOX4 plays an important role in many pathologies, including in stroke [40] and lung [41] and kidney fibrosis [42]. It also regulates the development of atherosclerosis [43,44]. The rabbit is a classical model animal in atherosclerosis research [13,14,45], making rabbit knockouts an ideal subject to study the lack of NOX4 gene function in the course of atherosclerosis.
Animal models in translational medicine usually share similar molecular targets, pathways, or phenotypes with humans. They can be very useful for predicting human responses, although ethical controversies regarding the use of experimental animals have arisen in the last century [46]. Besides rodents, most preclinical animal studies typically require one additional nonrodent species [47]. The use of nonrodents would increase the sensitivity of different tests for human applications [48]. An important disadvantage of nonrodent models is their genetic diversity, which can lead to differences in physiology and metabolism, as in the case of dog models [49]. Thus, inbred animals (and even nuclear-cloned animals) are the most controlled model systems, and their use can bypass several challenges associated with human studies [50]. On the other hand, biology is characterized by diversity as well as unity [51]. To avoid the questionable validity of an animal model system, genetic diversity should be assured. The dual problem of genetic diversity in animal model systems can be solved using mosaicism in transgenic founders of nonrodent species. In this paper, we show that a transgenic rabbit founder animal can produce multiallelic germline knockout strains that can be maintained as a closely related animal population and with high genetic diversity. Both are necessary for successful translational medical studies.

2. Materials and Methods

2.1. Ethics Statement

The rabbits used in this study were New Zealand white rabbits (Innovo Ltd., Isaszeg, Hungary). All animal studies were conducted in strict accordance with the recommendations and rules in the Hungarian Code of Practice for the Care and Use of Animals for Scientific Purposes, approved by the Animal Welfare and Research Ethics Committee at Agricultural Biotechnology Institute, National Agricultural Research and Innovation Centre (NARIC-ABC) and registered under permission number ÁK-ENG (PE/EA/58-2-2018) from Pest County’s governmental office. All efforts were made to minimize the suffering of animals.

2.2. Animals

Laboratory rabbits were maintained in the Animal Care Facility at NARIC-ABC. Animals were housed in individual cages with free access to food and water. Animals were kept under a standard light–dark cycle (06.00–18.00 h) at 19 °C.

2.3. Microinjection and Embryo Transfer

The protocol for superovulation of embryo donor does, embryo collection, microinjection of pronuclear-stage embryos, and transfer to recipient females has been described in our previous paper [52].
In summary, sexually mature does received an intramuscular injection of pregnant mare serum gonadotropin (PMSG) (ProSpec, Rehovot Israel), followed by an intravenous injection of human choriogonadotropin (hCG) (Choragon, Ferring GmbH, Kiel, Germany) 72 h later in order to induce superovulation. Donor rabbits were mated after the hCG injection. The oviducts were flushed with PBS–20%FCS (vol/vol) medium for collection of pronuclear-stage embryos. Zygotes were incubated in a Nuaire thermostat (38.5 °C, 5% CO2, 80% humidity) in the same embryo culture medium. A mixture of synthetic gRNA and transactivating RNA (Sigma-Merck, Budapest, Hungary) was added to capped Cas9 RNA (150 ng/µL) (Trilink, San Diego, CA, USA) to a final concentration of 5 ng/µL in an embryo microinjection buffer (1 mM Tris, pH 7.5, 0.1 mM EDTA). Cas9 mRNA is a highly purified capped form by CleanCap® technology preventing 5′ degradation and with increased half-life of mRNA. An aliquot of each batch used for microinjection was checked for degradation. Each batch was kept at 37 °C for 4 h previous to microinjection followed by agarose electrophoresis. Without any visible sign of degradation, RNA solution was ready for microinjection and the solution was injected into the cytoplasm of pronuclear-stage embryos. The injected embryos were incubated in embryo culture medium for 2–3 h, followed by the transfer of approximately 30–40 injected embryos into the oviducts of each recipient mother via laparoscopic surgery [52].
Guide RNA was designed using the publicly available E-CRISP program (http://www.e-crisp.org/E-CRISP/designcrispr.html) according to the second and fourth exon of the NOX4 gene (chromosome 1: 127,338,844–127,541,489, ENSOCUG00000016685.4). Guide RNAs are shown in Figure 1.

2.4. DNA Isolation from Blastocysts and Newborn Pups

Injected zygotes were individually collected at the blastocyst stage with a minimal amount of culture media in a 200 µL standard PCR microtube (Merck, Budapest, Hungary) and air-dried. Then, 5 µL of water was added and incubated at 95 °C for 5 min, followed by a 10 min incubation at −70 °C. This process was repeated twice. Embryos were then incubated in a 200 µL final volume of lysis buffer (10 mM Tris pH 8.0, 100 mM NaCl, 10 mM EDTA pH 8.0, 0.5% SDS, 0.4 mg/mL proteinase K) at 37 °C for 2 h. DNA was isolated using the phenol‒chloroform method. Equal volumes of phenol and chloroform were added to the mixture, shaken thoroughly, and centrifuged at 13,000 rpm for 10 min. The supernatant was mixed with a double volume of isopropanol, kept at −70 °C overnight, and centrifuged for 30 min at 4 °C. The resulting invisible pellet was then washed twice with 70% ethanol, air-dried, and dissolved in 10 µL water. Genomic DNA from tissue samples was isolated using the conventional phenol‒chloroform method [53].

2.5. Detection of Mutations in Embryos and Pups by PCR and Sequencing

The PCR primers used for mutation detection and Sanger sequencing are listed in Table 1. PCR reactions were set up with RedTaq Ready mix (Sigma, Budapest, Hungary) with standard PCR conditions (96 °C for 5 min; 33 cycles of 95 °C for 15 s, 58 °C for 15 s, 72 °C for 20 s; and a final step of 72 °C for 5 min followed by holding at 4 °C) in a ProFlex PCR system thermal cycler (Applied Biosystems, Budapest, Hungary).
PCR products were gel purified with NucleoSpin Gel and PCR Clean up Columns for gel extraction and a PCR cleanup kit (Macherey Nagel, Dueren, Germany) and cloned into pGEM-T vector (pGEM-T Easy Vector System I, Bioscience, Budapest, Hungary). Then, 4–5 PCR-positive plasmid clones were sequenced. Chromas software (Technelysium Pty Ltd., South Brisbane, Australia) was used for sequence analysis.

2.6. T7 Endonuclease I Assay

A T7 endonuclease I assay was performed to detect mutations in the target sequence [54]. After the extraction of genomic DNA from blastocysts and pups, the genomic region of NOX4 was PCR amplified (primers are shown in Table 1). The PCR product was denatured and reannealed under the following conditions: 95 °C for 5 min, 95–85 °C at −2 °C/s, 85–25 °C at −0.1 °C/s, holding at 4 °C. The reannealed fragments were digested with T7EI (NEB, Ipswich, MA, USA), separated, and visualized on an ethidium bromide-stained 2% agarose gel.

2.7. Off-Target Assay

Potential off-target sites of the sgRNAs were predicted using the CRISPR online design tool CRISPR/Cas-OFFinder RGEN (http://www.rgenome.net/cas-offinder/). The eight most promising off-target sites for NOX4 second exon sgRNAs were chosen for PCR and sequencing using REDTaq® ReadyMix (Sigma Aldrich, Budapest, Hungary) with the corresponding primers (Table 2). PCR products were analyzed on a 2% agarose gel, then purified and directly Sanger sequenced (Eurofins Genomics, Ebersberg, Germany). Chromas software and online blast tool (https://www.ensembl.org/Oryctolagus_cuniculus/Tools/Blast) was used for sequence analysis and evaluation of results.

3. Results

3.1. Testing of Guides and Production of Founder Knockout Animals

The mutation efficiency of guide RNAs was tested in cultured blastocysts. Both guides were effective in inducing mutations in the rabbit NOX4 gene. However, the guide RNA targeting the second exon of NOX4 had slightly higher mutation efficiency. Table 3 shows the ratio of total injected zygotes that developed to blastocyst stage to mutant blastocysts for the two guides designed for the second and fourth exons (18% and 16%, respectively).
In addition, it is beneficial to introduce an early stop codon in the second exon in order to avoid the presence of a functional truncated peptide. Hence, we chose the RNA guide targeting the second exon of the NOX4 gene to produce live animals.
Based on the results of embryo testing, a total of five knockout founder animals were produced, two males and three females, as summarized in Table 4. All mutations were heterozygous 7 bp and 8 bp deletions directly upstream of the PAM site with a couple of base differences: Animals #2, #3 and #4 acquired identical mutations (Figure 2), while animal #5 carried three different mutated alleles. We established heterozygous and homozygous genome-edited rabbit sublines by consecutive brother–sister mating from founder animal #5.
Animal #5 passed on four different alleles to the F1 generation (Figure 3 and Figure 4). The most frequent allele was an 8 bp deletion (∆8). The other allele contained a 128 bp deletion (∆128), including an intronic region. The third allele type was the most irregular, with deletions and insertions adding up to a 104 bp deletion in total (∆104) upstream of the PAM sequence. A wild-type allele also appeared in the F1 generation, demonstrating the presence of a fourth allele. We analyzed the expression level of NOX4 in different tissues of a selected homozygous individual from line ∆8 by RT-qPCR. Expression pattern matched to an expected -/- phenotype (data not shown).

3.2. Off-Target Analysis

The selected potential off-target sites were amplified by PCR using genomic DNA from both the wild-type animal and founder rabbit #5 and evaluated by DNA sequencing. Eight candidate off-target sites were analyzed. In all these cases, no difference was observed (see Figure 5), so no off-target event was detected at any of the genomic locations.

3.3. Heritability of Deletions

Founder animal #5 was used as a sperm donor in four different artificial inseminations. Female partner animals originated from two different available sub-breeds of New Zealand White rabbits to represent different genotypes. Later, the same females were used in two more consecutive matings to represent animal populations with close relationships (both parents were the same). Animal #5, the founder male, had a total of four litters with an average litter size of 3–10 pups/litter. The three mutants and the wild-type allele appeared with varying frequencies among the pups in the F1 generation. The most frequent allele was ∆8 with 50%, followed by ∆128 and ∆104 with 36% and 10%, respectively. The wild-type allele appeared in only one female (4%). There was an alteration from Mendelian inheritance according to the sex of the animals. Two-thirds of the population was female, so male offspring was underrepresented by 14% compared to the total number of animals. This difference might be due to the small sample size (28 pups in total). The female/male ratio showed the same pattern among all three mutated genotypes (70:30, 64:36, and 67:33 in ∆128, ∆8, and ∆104, respectively). The data are shown in Table 5. In the F2 generation, when a heterozygous male and female were bred, homozygous NOX4 KO mutants of both sexes were born. We initialized the analyses of phenotype, such as litter size and preweaning lethality, and have not found any difference compared to wild-type litters. We have proof of homozygous animal survival and of the fertility of both sexes. More data with a higher sample size are needed to confirm or disprove the differences in sex ratio in NOX4 knockout rabbits. The establishment of homozygous knockout population is in progress.

4. Discussion

The results of our study show the successful generation of several NADPH oxidase 4 knockout rabbit lines. The NOX4 gene plays an important role in biological processes, and reactive oxygen species have a modulatory effect on the physiological functions of diverse mammal organs. NOX4 knockout mouse models have recently been demonstrated to be useful models to study the regulation of insulin secretion [55]. Other research has shown the role of NOX4 in liver fibrosis in connection with gut microbiota [56]. In addition, the protective effect of NOX4 knockdown has also been demonstrated in sepsis-induced lung injury in mice [57]. The broad spectrum of NOX4 function creates the need for better animal models to make the best mammalian system for the purposes of translational medicine.
The efficiency of CRISPR/Cas9 to induce site specific mutations in rabbits is a complex issue. Chromatin structure of the targeted genomic region affects the availability of the site to CRIPSR/Cas9 complexes. An open chromatin structure predicts greater efficiency. The concentration of gRNA is also a crucial element. The encountered 16–18% efficiency of mutated blastocysts is within the normal range. However, the efficiency of targeting varies greatly between 10–100% according to scientific data [1].
Five founder animals were generated in total, of which three acquired identical 8 bp deletions. This phenomenon seems striking, but robust analysis of CRISPR-mediated genome editing in cell culture systems has shown that DNA editing varies considerably between sites, with some targets shown to have a highly preferred indel while others display a wide range of infrequent indels [58]. Presumably, the pattern is dependent on both DNA sequence and chromatin structure.
Interestingly, one of the NOX4 KO founder males turned out to be a genetic mosaic animal with germline transmission of three distinct knockout alleles besides the wild-type allele to its offspring. The ∆8 subline of founder animal #5 carried a short 8 bp deletion directly upstream of the PAM site, which is a common type of modification induced by the CRISPR/Cas9 method according to our own observations and the literature [59]. The other two modified alleles carried longer deletions, a 128 bp deletion in the case of the ∆128 subline, and a more exciting deletion‒insertion‒rearrangement type of modification in the case of the ∆104 rabbit subline. Complex targeting events in genome-edited animals have previously been detected [60]. Both modifications—∆104 and ∆128—make the detection of the knockout allele a simple one-step procedure, with allele-specific PCR sparing us the burden of T7 assays in our future experiments.
We found a deviation of the male/female ratio from the expected Mendelian pattern of inheritance: 14% fewer males were born in the F1 litters of the #5 founder male. These data must be closely examined in our future studies and while evaluating F2-generation data.
Mosaic events during genome editing are generally unwanted events. There are known strategies to reduce the genetic mosaicism produced by CRISPR/Cas9 system [61]. Mosaic events can be found during rabbit genome editing using CRISPR/Cas9 methods after allele screening [2,8,62,63,64,65,66]. Our opinion is that mosaic events can be useful in animal models of human diseases. To profit from the fact that mosaic animals represent different edited alleles, we developed a new breeding strategy (Figure 6).
The mosaic animal is mated consecutively with its counterpart, resulting in litters whose newborns are closely related but represent different transgenic lines with different targeting events. We suppose that analyzing these lines would result in predictable and equal phenotypic differences, ensuring the observations are the outcome of genome editing but not off-target events. On the other hand, mosaic founders are mated with different genetic background partners, which will result in a population of newborns with a diverse genetic heritage. In this case, small differences during phenotyping are tolerated and can presumably be explained. Most of human diseases are multifactorial and multigenic. Even single inheritance disorders can show diverse appearance depending on genetic background. To create the best animal model of the analyzed disorder, it is necessary to keep genetic divergence within the model population. On the other hand, genetic diversity can cause uninterpretable deviations sometimes. This is one important reason why most studies use inbred mice as model animals. Inbred strains usually react in a predictable way. Our breeding strategy involved combining the advantages of inbred and diverse genetic populations. Although this strategy uses more animals and the phenotypic examination is more complex, the resulted biological answer closely resembles the progression of human diseases. Using our new mating system, genetically divergent and homogeneous genome-edited populations can be produced in parallel, which is beneficial in translational medicine studies.

Author Contributions

Conceptualization, M.G., Z.B. and L.H.; Data curation, M.G., L.H. and L.B.; Formal analysis, L.H. and L.B.; Funding acquisition, M.G. and Z.B.; Investigation, T.P., M.G., Z.B., L.H. and L.B.; Methodology, T.P., G.L.P., M.M., N.L., A.K. and L.B.; Resources, M.M. and N.L.; Validation, T.P., G.L.P.and G.S.; Visualization, L.B.; Writing—original draft, L.H. and L.B.; Writing—review & editing, M.G., N.L. and Z.B. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the Hungarian NVKP Grant No. NVKP_16-1-2016-0039 and by grant from the National Research Development and Innovation Office (K119955).

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Yang, D.; Xu, J.; Zhu, T.; Fan, J.; Lai, L.; Zhang, J.; Chen, Y.E. Effective gene targeting in rabbits using RNA-guided Cas9 nucleases. J. Mol. Cell Biol. 2014, 6, 97–99. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Guo, R.; Wan, Y.; Xu, D.; Cui, L.; Deng, M.; Zhang, G.; Jia, R.; Zhou, W.; Wang, Z.; Deng, K.; et al. Generation and evaluation of Myostatin knock-out rabbits and goats using CRISPR/Cas9 system. Sci. Rep. 2016, 6, 29855. [Google Scholar] [CrossRef] [PubMed]
  3. Song, Y.; Xu, Y.; Deng, J.; Chen, M.; Lu, Y.; Wang, Y.; Yao, H.; Zhou, L.; Liu, Z.; Lai, L.; et al. CRISPR/Cas9-mediated mutation of tyrosinase (Tyr) 3′ UTR induce graying in rabbit. Sci. Rep. 2017, 7, 1–8. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Song, Y.; Sui, T.; Zhang, Y.; Wang, Y.; Chen, M.; Deng, J.; Chai, Z.; Lai, L.; Li, Z. Genetic deletion of a short fragment of glucokinase in rabbit by CRISPR/Cas9 leading to hyperglycemia and other typical features seen in MODY-2. Cell. Mol. Life Sci. 2020, 77, 3265–3277. [Google Scholar] [CrossRef]
  5. Yuan, T.; Zhong, Y.; Wang, Y.; Zhang, T.; Lu, R.; Zhou, M.; Lu, Y.; Yan, K.; Chen, Y.; Hu, Z.; et al. Generation of hyperlipidemic rabbit models using multiple sgRNAs targeted CRISPR/Cas9 gene editing system. Lipids Health Dis. 2019, 18, 1–9. [Google Scholar] [CrossRef] [Green Version]
  6. Sui, T.; Lau, Y.S.; Liu, D.; Liu, T.; Xu, L.; Gao, Y.; Lai, L.; Li, Z.; Han, R. A novel rabbit model of Duchenne muscular dystrophy generated by CRISPR/Cas9. DMM Dis. Model. Mech. 2018, 11, 1–9. [Google Scholar] [CrossRef] [Green Version]
  7. Li, H.; Li, Z.; Xiao, N.; Su, X.; Zhao, S.; Zhang, Y.; Cui, K.; Liu, Q.; Shi, D. Site-specific integration of rotavirus VP6 gene in rabbit β-casein locus by CRISPR/Cas9 system. Vitr. Cell. Dev. Biol.-Anim. 2019, 55, 586–597. [Google Scholar] [CrossRef]
  8. Yang, D.; Song, J.; Zhang, J.; Xu, J.; Zhu, T.; Wang, Z.; Lai, L.; Chen, Y.E. Identification and characterization of rabbit ROSA26 for gene knock-in and stable reporter gene expression. Sci. Rep. 2016, 6, 25161. [Google Scholar] [CrossRef] [Green Version]
  9. Liu, H.; Sui, T.; Liu, D.; Liu, T.; Chen, M.; Deng, J.; Xu, Y.; Li, Z. Multiple homologous genes knockout (KO) by CRISPR/Cas9 system in rabbit. Gene 2018, 647, 261–267. [Google Scholar] [CrossRef]
  10. Liu, Z.; Chen, M.; Chen, S.; Deng, J.; Song, Y.; Lai, L.; Li, Z. Highly efficient RNA-guided base editing in rabbit. Nat. Commun. 2018, 9, 1–10. [Google Scholar] [CrossRef] [Green Version]
  11. Yang, D.; Zhang, J.; Xu, J.; Zhu, T.; Fan, Y.; Fan, J.; Chen, Y.E. Production of apolipoprotein C-III knockout rabbits using zinc finger nucleases. J. Vis. Exp. 2013, 81, 1–7. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  12. Lozano, W.M.; Arias-Mutis, O.J.; Calvo, C.J.; Chorro, F.J.; Zarzoso, M. Diet-induced rabbit models for the study of metabolic syndrome. Animals 2019, 9, 463. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. Fan, J.; Kitajima, S.; Watanabe, T.; Xu, J.; Zhang, J.; Liu, E.; Chen, Y.E. Rabbit models for the study of human atherosclerosis: From pathophysiological mechanisms to translational medicine. Pharmacol. Ther. 2015, 146, 104–119. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  14. Baumgartner, C.; Brandl, J.; Münch, G.; Ungerer, M. Rabbit models to study atherosclerosis and its complications—Transgenic vascular protein expression In Vivo. Prog. Biophys. Mol. Biol. 2016, 121, 131–141. [Google Scholar] [CrossRef] [PubMed]
  15. Bősze, Z.; Major, P.; Baczkó, I.; Odening, K.E.; Bodrogi, L.; Hiripi, L.; Varró, A. The potential impact of new generation transgenic methods on creating rabbit models of cardiac diseases. Prog. Biophys. Mol. Biol. 2016, 121, 123–130. [Google Scholar] [CrossRef]
  16. Koike, T.; Liang, J.; Wang, X.; Ichikawa, T.; Shiomi, M.; Liu, G.; Sun, H.; Kitajima, S.; Morimoto, M.; Watanabe, T.; et al. Overexpression of Lipoprotein Lipase in Transgenic Watanabe Heritable Hyperlipidemic Rabbits Improves Hyperlipidemia and Obesity. J. Biol. Chem. 2004, 279, 7521–7529. [Google Scholar] [CrossRef] [Green Version]
  17. Jolivet, G.; Braud, S.; DaSilva, B.; Passet, B.; Harscoët, E.; Viglietta, C.; Gautier, T.; Lagrost, L.; Daniel-Carlier, N.; Houdebine, L.M.; et al. Induction of body weight loss through RNAi- knockdown of APOBEC1 gene expression in transgenic rabbits. PLoS ONE 2014, 9, e106655. [Google Scholar] [CrossRef] [Green Version]
  18. Gonzalez-Bulnes, A.; Chavatte-Palmer, P. Contribution of Large Animals to Translational Research on Prenatal Programming of Obesity and Associated Diseases. Curr. Pharm. Biotechnol. 2017, 18, 541–551. [Google Scholar] [CrossRef]
  19. Osteil, P.; Moulin, A.; Santamaria, C.; Joly, T.; Jouneau, L.; Aubry, M.; Tapponnier, Y.; Archilla, C.; Schmaltz-Panneau, B.; Lecardonnel, J.; et al. A Panel of Embryonic Stem Cell Lines Reveals the Variety and Dynamic of Pluripotent States in Rabbits. Stem. Cell Rep. 2016, 7, 383–398. [Google Scholar] [CrossRef] [Green Version]
  20. Tancos, Z.; Nemes, C.; Polgar, Z.; Gocza, E.; Daniel, N.; Stout, T.A.E.; Maraghechi, P.; Pirity, M.K.; Osteil, P.; Tapponnier, Y.; et al. Generation of rabbit pluripotent stem cell lines. Theriogenology 2012, 78, 1774–1786. [Google Scholar] [CrossRef]
  21. Quan, L.; Chen, Y.; Song, J.; Yan, Q.; Zhang, Q.; Lai, S.; Fan, N.; Xin, J.; Zou, Q.; Lai, L. Establishment of a rabbit Oct4 promoter-based EGFP reporter system. PLoS ONE 2014, 9, e109728. [Google Scholar] [CrossRef] [Green Version]
  22. Zhang, S.; Xiang, S.; Yang, J.; Shi, J.; Guan, X.; Jiang, J.; Wei, Y.; Luo, C.; Shi, D.; Lu, F. Optimization of parthenogenetic activation of rabbit oocytes and development of rabbit embryo by somatic cell nuclear transfer. Reprod Domest. Anim. 2019, 54, 258–269. [Google Scholar] [CrossRef]
  23. Barman, A.; Deb, B.; Chakraborty, S. A glance at genome editing with CRISPR–Cas9 technology. Curr. Genet. 2020, 66, 447–462. [Google Scholar] [CrossRef] [PubMed]
  24. Adli, M. The CRISPR tool kit for genome editing and beyond. Nat. Commun. 2018, 9, 1–13. [Google Scholar] [CrossRef] [PubMed]
  25. Sakurai, T.; Watanabe, S.; Kamiyoshi, A.; Sato, M.; Shindo, T. A single blastocyst assay optimized for detecting CRISPR/Cas9 system-induced indel mutations in mice. BMC Biotechnol. 2014, 14, 1–11. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  26. Kleinstiver, B.P.; Pattanayak, V.; Prew, M.S.; Tsai, S.Q.; Nguyen, N.T.; Zheng, Z.; Keith Joung, J. High-fidelity CRISPR-Cas9 variants with undetectable genome- wide off-targets. Nature 2016, 528, 490–495. [Google Scholar] [CrossRef] [Green Version]
  27. Anderson, K.R.; Haeussler, M.; Watanabe, C.; Janakiraman, V.; Lund, J.; Modrusan, Z.; Stinson, J.; Bei, Q.; Buechler, A.; Yu, C.; et al. CRISPR off-target analysis in genetically engineered rats and mice. Nat. Methods 2018, 15, 512–514. [Google Scholar] [CrossRef]
  28. Mehravar, M.; Shirazi, A.; Nazari, M.; Banan, M. Mosaicism in CRISPR/Cas9-mediated genome editing. Dev. Biol. 2019, 445, 156–162. [Google Scholar] [CrossRef]
  29. Yen, S.-T.; Zhang, M.; Deng, J.M.; Usman, S.J.; Smith, C.N.; Parker-Thornburg, J.; Swinton, P.G.; Martin, J.F.; Behringer, R.R. Somatic mosaicism and allele complexity induced by CRISPR/Cas9 RNA injections in mouse zygotes. Dev. Biol. 2014, 393, 3–9. [Google Scholar] [CrossRef] [Green Version]
  30. Mizuno, S.; Thi, T.; Dinh, H.; Kato, K. Simple generation of albino C57BL/6J mice with G291T mutation in the tyrosinase gene by the CRISPR/Cas9 system. Mamm. Genome 2014, 25, 327–334. [Google Scholar] [CrossRef]
  31. Sultana, F.; Hatori, M.; Shimozawa, N.; Ebisawa, T.; Sankai, T. Continuous observation of rabbit preimplantation embryos in vitro by using a culture device connected to a microscope. J. Am. Assoc. Lab. Anim. Sci. 2009, 48, 52–56. [Google Scholar] [PubMed]
  32. Hiripi, L.; Negre, D.; Cosset, F.L.; Kvell, K.; Czömpöly, T.; Baranyi, M.; Gócza, E.; Hoffmann, O.; Bender, B.; Bosze, Z. Transgenic rabbit production with simian immunodeficiency virus-derived lentiviral vector. Transgenic Res. 2010, 19, 799–808. [Google Scholar] [CrossRef] [PubMed]
  33. Atashi, F.; Modarressi, A.; Pepper, M.S. The role of reactive oxygen species in mesenchymal stem cell adipogenic and osteogenic differentiation: A review. Stem Cells Dev. 2015, 24, 1150–1163. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  34. Yao, M.I.N.; Gao, F.; Wang, X.; Shi, Y.; Liu, S.; Duan, H. Nox4 is involved in high glucose—induced apoptosis in renal tubular epithelial cells via Notch pathway. Mol. Med. Rep. 2017, 15, 4319–4325. [Google Scholar] [CrossRef] [Green Version]
  35. Grandvaux, N.; Soucy-faulkner, A.; Fink, K. Innate host defense: Nox and Duox on phox’s tail. Biochimie 2007, 89, 1113–1122. [Google Scholar] [CrossRef]
  36. Feng, C.; Zhang, Y.; Yang, M.; Lan, M.; Liu, H.; Huang, B.; Zhou, Y. Oxygen-Sensing Nox4 Generates Genotoxic ROS to Induce Premature Senescence of Nucleus Pulposus Cells through MAPK and NF- κ B Pathways. Oxid. Med. Cell Longev. 2017, 2017, 7426458. [Google Scholar] [CrossRef] [Green Version]
  37. Liu, C.; Hua, N.; Fu, X.; Pan, Y.; Li, B.; Li, X. Metformin Regulates the Expression of SK2 and SK3 in the Atria of Rats with Type 2 Diabetes Mellitus Through the NOX4 / p38MAPK Signaling Pathway. Cardiovasc. Pharmacol. 2018, 72, 205–213. [Google Scholar] [CrossRef]
  38. Song, S.; Xiao, X.; Guo, D.; Mo, L.; Bu, C.; Ye, W.; Den, Q.; Liu, S.; Yang, X. Phytomedicine Protective effects of Paeoni florin against AOPP-induced oxidative injury in HUVECs by blocking the ROS-HIF-1 α / VEGF pathway. Phytomedicine 2017, 34, 115–126. [Google Scholar] [CrossRef]
  39. Yang, Q.; Wu, F.; Wang, J.; Gao, L.; Wei, B.; Zhou, L.; Wen, J.; Ma, T. Nox4 in Renal Diseases: An Update. Free Radic. Biol. Med. 2018, 124, 466–472. [Google Scholar] [CrossRef]
  40. Radermacher, K.A.; Wingler, K.; Langhauser, F.; Altenho, S.; Kleikers, P.; Hermans, J.J.R.; Hrabe, M.; Kleinschnitz, C.; Schmidt, H.H.H.W. Neuroprotection After Stroke by Targeting NOX4 As a Source of Oxidative Stress. Antioxid. Redox. Signal. 2013, 18, 1418–1427. [Google Scholar] [CrossRef] [Green Version]
  41. Meng, Y.; Li, T.; Zhou, G.-S.; Chen, Y.; Yu, C.-H.; Pang, M.-X.; Li, W.; Li, Y.; Zhang, W.-Y.; Li, X. The angiotensin-converting enzyme 2/angiotensin (1-7)/Mas axis protects against lung fibroblast migration and lung fibrosis by inhibiting the NOX4-derived ROS-mediated RhoA/Rho kinase pathway. Antioxid. Redox Signal. 2015, 22, 241–258. [Google Scholar] [CrossRef] [PubMed]
  42. Nlandu Khodo, S.; Dizin, E.; Sossauer, G.; Szanto, I.; Martin, P.-Y.; Feraille, E.; Krause, K.H.; de Seigneux, S. NADPH-oxidase 4 protects against kidney fibrosis during chronic renal injury. J. Am. Soc. Nephrol. 2012, 23, 1967–1976. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  43. Lozhkin, A.; Vendrov, A.E.; Pan, H.; Wickline, S.A.; Nageswara, R.; Runge, M.S. NADPH oxidase 4 regulates vascular inflammation in aging and atherosclerosis. J. Mol. Cell Cardiol. 2017, 102, 10–21. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  44. Schürmann, C.; Rezende, F.; Kruse, C.; Yasar, Y.; Löwe, O.; Fork, C.; Van De Sluis, B.; Bremer, R.; Weissmann, N.; Shah, A.M.; et al. The NADPH oxidase Nox4 has anti-atherosclerotic functions. Eur. Heart J. 2015, 36, 3447–3456. [Google Scholar] [CrossRef] [Green Version]
  45. Fan, J.; Chen, Y.; Yan, H.; Niimi, M.; Wang, Y.; Liang, J. Principles and Applications of Rabbit Models for Atherosclerosis Research. J. Atheroscler. Thromb. 2018, 25, 213–220. [Google Scholar] [CrossRef] [Green Version]
  46. Faggion, C.M. Animal research as a basis for clinical trials. Eur. J. Oral Sci. 2015, 123, 61–64. [Google Scholar] [CrossRef]
  47. Bailey, J.; Thew, M.; Balls, M. An Analysis of the Use of Animal Models in Predicting Human Toxicology and Drug Safety. Altern. Lab. Anim. 2014, 42, 181–199. [Google Scholar] [CrossRef] [Green Version]
  48. Box, R.J.; Spielmann, H. Use of the dog as non-rodent test species in the safety testing schedule associated with the registration of crop and plant protection products (pesticides): Present status. Arch. Toxicol. 2005, 79, 615–626. [Google Scholar] [CrossRef]
  49. Gilmore, K.M.; Greer, K.A. Why is the dog an ideal model for aging research? Exp. Gerontol. 2015, 71, 14–20. [Google Scholar] [CrossRef]
  50. Burkhardt, A.M.; Zlotnik, A. Translating translational research: Mouse models of human disease. Cell. Mol. Immunol. 2013, 10, 373–374. [Google Scholar] [CrossRef] [Green Version]
  51. Perlman, R.L. Mouse models of human disease an evolutionary perspective. Evol. Med. Public Health 2016, 2016, 170–176. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  52. Ivics, Z.; Hiripi, L.; Hoffmann, O.I.; Mátés, L.; Yau, T.Y.; Bashir, S.; Zidek, V.; Landa, V.; Geurts, A.; Pravenec, M.; et al. Germline transgenesis in rabbits by pronuclear microinjection of Sleeping Beauty transposons. Nat. Protoc. 2014, 9, 794–809. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  53. Sambrook, J.; Russell, D.W. Molecular Cloning: A Laboratory Manual, 4th ed.; Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY, USA, 2012; ISBN 978-1-936113-42-2. [Google Scholar]
  54. Imanishi, M.; Negi, S.; Sugiura, Y. Non-FokI-based zinc finger nucleases. Methods Mol. Biol. 2010, 649, 337–349. [Google Scholar] [CrossRef] [PubMed]
  55. Plecitá-hlavatá, L.; Jab, M.; Holendová, B.; Tauber, J.; Berková, Z.; Cahová, M.; Schröder, K.; Brandes, R.P.; Siemen, D.; Je, P. Glucose-Stimulated Insulin Secretion Fundamentally Requires H2O2 Signaling by NADPH Oxidase 4. Diabetes 2020, 69, 1341–1354. [Google Scholar] [CrossRef] [PubMed]
  56. Wan, S.; Nie, Y.; Zhang, Y.; Huang, C.; Zhu, X. Gut Microbial Dysbiosis Is Associated with Profibrotic Factors in Liver Fibrosis Mice. Front. Cell. Infect. Microbiol. 2020, 10, 1–12. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  57. Jiang, J.; Huang, K.; Xu, S.; Garcia, J.G.N.; Wang, C.; Cai, H. Redox Biology Targeting NOX4 alleviates sepsis-induced acute lung injury via attenuation of redox-sensitive activation of CaMKII/ERK1/2/MLCK and endothelial cell barrier dysfunction. Redox Biol. 2020, 36, 101638. [Google Scholar] [CrossRef] [PubMed]
  58. Chakrabarti, A.M.; Henser-brownhill, T.; Monserrat, J.; Poetsch, A.R.; Luscombe, N.M.; Scaffidi, P. Target-Specific Precision of CRISPR-Mediated Genome Editing. Mol. Cell 2019, 73, 699–713. [Google Scholar] [CrossRef] [Green Version]
  59. Labun, K.; Guo, X.; Chavez, A.; Church, G.; Gagnon, J.A.; Valen, E. Accurate analysis of genuine CRISPR editing events with ampliCan. Genome Res. 2019, 29, 843–847. [Google Scholar] [CrossRef] [Green Version]
  60. Shin, H.Y.; Wang, C.; Lee, H.K.; Yoo, K.H.; Zeng, X.; Kuhns, T.; Yang, C.M.; Mohr, T.; Liu, C.; Hennighausen, L. CRISPR/Cas9 targeting events cause complex deletions and insertions at 17 sites in the mouse genome. Nat. Commun. 2017, 8, 15464. [Google Scholar] [CrossRef]
  61. Lamas-Toranzo, I.; Galiano-Cogolludo, B.; Cornudella-Ardiaca, F.; Cobos-Figueroa, J.; Ousinde, O.; Bermejo-Álvarez, P. Strategies to reduce genetic mosaicism following CRISPR-mediated genome edition in bovine embryos. Sci. Rep. 2019, 9, 14900. [Google Scholar] [CrossRef] [Green Version]
  62. Yan, Q.; Zhang, Q.; Yang, H.; Zou, Q.; Tang, C.; Fan, N. Generation of multi-gene knockout rabbits using the Cas9 / gRNA system. Cell Regen. 2014, 3, 1–11. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  63. Honda, A.; Hirose, M.; Sankai, T.; Yasmin, L. Single-step generation of rabbits carrying a targeted allele of the tyrosinase gene using CRISPR / Cas9. Exp. Anim. 2015, 64, 31–37. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  64. Lv, Q.; Yuan, L.; Deng, J.; Chen, M.; Wang, Y.; Zeng, J.; Li, Z.; Lai, L. Efficient Generation of Myostatin Gene Mutated Rabbit by CRISPR/Cas9. Sci. Rep. 2016, 6, 25029. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  65. Song, Y.; Yuan, L.; Wang, Y.; Chen, M.; Deng, J.; Lv, Q.; Sui, T.; Li, Z.; Lai, L. Efficient dual sgRNA-directed large gene deletion in rabbit with CRISPR/Cas9 system. Cell. Mol. Life Sci. 2016, 73, 2959–2968. [Google Scholar] [CrossRef] [PubMed]
  66. Yuan, L.; Sui, T.; Chen, M.; Deng, J.; Huang, Y.; Zeng, J.; Lv, Q.; Song, Y.; Li, Z.; Lai, L. OPEN CRISPR / Cas9-mediated GJA8 knockout in rabbits recapitulates human congenital cataracts. Sci. Rep. 2016, 6, 22024. [Google Scholar] [CrossRef] [Green Version]
Applsci 10 08508 g001 550
Figure 1. These guide RNAs targeting the second and fourth exons of the rabbit NADPH oxidase 4 gene for the CRISPR/Cas9 system. The second exon gRNA with PAM sequence is UGGUGGAGGUAAUGGUACUC-TGG. The fourth exon gRNA with PAM sequence is UAGAGCACCACAAGUUAUA-TGG.
Figure 1. These guide RNAs targeting the second and fourth exons of the rabbit NADPH oxidase 4 gene for the CRISPR/Cas9 system. The second exon gRNA with PAM sequence is UGGUGGAGGUAAUGGUACUC-TGG. The fourth exon gRNA with PAM sequence is UAGAGCACCACAAGUUAUA-TGG.
Applsci 10 08508 g001
Applsci 10 08508 g002 550
Figure 2. Comparison of mutations in NOX4 knockout rabbit founders. The gRNA and the target in the gene followed by the PAM sequence are highlighted in red. The yellow spaces indicate the sites of mutation. The second exon is underlined with a black line. Animal #1 had a 7 bp deletion; #2–4 had identical 8 bp deletions. All four deletions were directly followed by the PAM sequence.
Figure 2. Comparison of mutations in NOX4 knockout rabbit founders. The gRNA and the target in the gene followed by the PAM sequence are highlighted in red. The yellow spaces indicate the sites of mutation. The second exon is underlined with a black line. Animal #1 had a 7 bp deletion; #2–4 had identical 8 bp deletions. All four deletions were directly followed by the PAM sequence.
Applsci 10 08508 g002
Applsci 10 08508 g003 550
Figure 3. Comparison of mutations originating from the #5 founder male. The gRNA and the target in the gene followed by the PAM sequence are highlighted in red. The yellow spaces show the sites of deletions. The second exon is underlined with a black line. The ∆8 mutation is a small deletion of eight base pairs, indicated in yellow. In ∆104, a TAAT insertion is present, highlighted in blue, and a couple of single base pair changes appeared in the sequence of ∆104 and ∆8, which, in the case of the ∆104 mutated allele, was probably the consequence of imperfect NHEJ repair. However, in the ∆8 mutated allele, it might be a small nucleotide polymorphism not related to NHEJ.
Figure 3. Comparison of mutations originating from the #5 founder male. The gRNA and the target in the gene followed by the PAM sequence are highlighted in red. The yellow spaces show the sites of deletions. The second exon is underlined with a black line. The ∆8 mutation is a small deletion of eight base pairs, indicated in yellow. In ∆104, a TAAT insertion is present, highlighted in blue, and a couple of single base pair changes appeared in the sequence of ∆104 and ∆8, which, in the case of the ∆104 mutated allele, was probably the consequence of imperfect NHEJ repair. However, in the ∆8 mutated allele, it might be a small nucleotide polymorphism not related to NHEJ.
Applsci 10 08508 g003
Applsci 10 08508 g004 550
Figure 4. Detection of mutation is performed with PCR and/or T7 digestion. MW = molecular weight marker. (1–2) T7 assay and PCR of F1 heterozygous offspring of ∆8 line, respectively; (3–4) PCR of heterozygous offspring of ∆104 and ∆128 line, respectively; (5) PCR of founder male #5; (6–7) PCR of wild-type animal and no template control.
Figure 4. Detection of mutation is performed with PCR and/or T7 digestion. MW = molecular weight marker. (1–2) T7 assay and PCR of F1 heterozygous offspring of ∆8 line, respectively; (3–4) PCR of heterozygous offspring of ∆104 and ∆128 line, respectively; (5) PCR of founder male #5; (6–7) PCR of wild-type animal and no template control.
Applsci 10 08508 g004
Applsci 10 08508 g005 550
Figure 5. Sequence analysis of the eight candidate off-target sites predicted for NOX4 second exon sgRNA.
Figure 5. Sequence analysis of the eight candidate off-target sites predicted for NOX4 second exon sgRNA.
Applsci 10 08508 g005
Applsci 10 08508 g006 550
Figure 6. Optimal breeding strategy for generation of transgenic mosaic founder animals for use in translational medicine. Colored dots represent different mosaic alleles of a gene of interest, while colored rods represent inherited alleles in the F1 generation. The different gray background of rabbits highlights the variation in the genetic background.
Figure 6. Optimal breeding strategy for generation of transgenic mosaic founder animals for use in translational medicine. Colored dots represent different mosaic alleles of a gene of interest, while colored rods represent inherited alleles in the F1 generation. The different gray background of rabbits highlights the variation in the genetic background.
Applsci 10 08508 g006
Table
Table 1. PCR primers used for mutation detection and sequencing.
Table 1. PCR primers used for mutation detection and sequencing.
PrimerSequenceProduct Size (Base Pairs)
2. exon-forwardTTGCTTGGATTTCACCCTGC312
2. exon-reverseAGTCTGGTGGCTAAGTCTGC
4. exon-forwardACATCTCACCAACGTTTGA386
4. exon-reverseTAGACAATCATATTTAAAC
2nd exon seq. primer-forwardCAACTAACAAAACTTGACGCC1059
2nd exon seq. primer-reverseAAGCCACTGAAAAACACCC
Table
Table 2. The eight most potent off-target sites in the rabbit genome predicted by the CRISPR/Cas-OFFinder RGEN tool. Lowercase letters indicate the sites of mismatches compared to the target sequence.
Table 2. The eight most potent off-target sites in the rabbit genome predicted by the CRISPR/Cas-OFFinder RGEN tool. Lowercase letters indicate the sites of mismatches compared to the target sequence.
Off-TargetsOff-Target Sequence Compared to Target DNAChromosomeLocationNumber of MismatchesPrimers
NOX4 2nd exon target siteTGGTGGAGGTAATGGTACTCNGG chr11273397450
Off-target-1TGtTGGtGGTAATGGTACTtGGGchr11354976703forward AAGAGACAGGAGACAGGAAG reverse ATTAGGAAAGCAATGTGAGGG
Off-target-2TGGTGGAGGTAATGGTgaTCGGGchr10318759322forward AAAGACAACCGAAAGGCAG reverse AGCATAATGAGATTAAGCCCAG
Off-target-3TGGaGGAGGTAATGaTcCTCTGGchr11371385943forward ATGATGAGATGGAGGCAAGG reverse TGTGTGATTATTGGCGGAGA
Off-target-4TGGTGGAGGTgATGGTgCTCAGGchr14815412882forward TGACCCTTAACAGTCCCTCC reverse CCTAAACCCCTACACCTACC
Off-target-5TGaTGGAGGTAATGGTAtTtGGGchr15453120423forward AGGAAGAAAGTAGGGCCAGT reverse CTGCCCAGCTGAGTTGTAGT
Off-target-6TGGTGGtGGTggTGGTACTCTGGchr2997986453forward GGGTGAACCAGCAGTAAAG reverse GTTCAGATAGACAGCCCCAG
Off target-7TGGTGGAGaTAATGGgAtTCTGGchr8799713733forward AAGAAACGTGCCAGGGGATT reverse TTAACCCCTACGTCATGGCC
Off target-8TGGTGtAGGgAATGGTACTCCGGchr91112357942forward GGTGTAATCCAGGAACAATGCT reverse CATGCCCCAGGACTGTAGAG
Table
Table 3. Results of microinjection of Cas9 and targeting gRNAs into rabbit zygotes. The second and fourth exons were targeted, and both guides were successful in inducing targeting events with almost equal efficiency.
Table 3. Results of microinjection of Cas9 and targeting gRNAs into rabbit zygotes. The second and fourth exons were targeted, and both guides were successful in inducing targeting events with almost equal efficiency.
Targeted Exon of NOX4Total/Mutant BlastocystsRatio
2nd exon11/218%
4th exon18/316%
Table
Table 4. Summary of mutations in NOX4 KO founder rabbits. One male (#1) and three female (#2–4) rabbits had 7–8 bp deletions. Male #5 carried three distinct alleles with alternative mutations.
Table 4. Summary of mutations in NOX4 KO founder rabbits. One male (#1) and three female (#2–4) rabbits had 7–8 bp deletions. Male #5 carried three distinct alleles with alternative mutations.
Code of Founder AnimalSexMutationConsequence
#1♂7 bp deletion (GGTACTC)early stop codon
#2♀8 bp deletion (TGGTACTC)early stop codon
#3♀8 bp deletion (TGGTACTC)early stop codon
#4♀8 bp deletion (TGGTACTC)early stop codon
#5♂allele A: 8 bp deletion (ACTCTGGC)early stop codon
allele B: 128 bp deletionearly stop codon
allele C: 104 bp deletion in totalearly stop codon
Table
Table 5. Results of breeding of #5 founder male.
Table 5. Results of breeding of #5 founder male.
Rabbit Subline∆128 ∆8 ∆104 Wild-TypeAnimals Born
sex♀♂♀♂♀♂♀♂
number of animals7395211028
ratio to total (%)25%11%32%18%7%3.50%3.50%0
ratio of genotype to total (%) 36% 50% 10% 4%
sex ratio within genotype (%)70%30%64%36%67%33%100%0%
sex ratio (%)♀1968%
♂932%
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Pintér, T.; Geiszt, M.; Petheő, G.L.; Mihálffy, M.; Skoda, G.; Lipták, N.; Kerekes, A.; Bősze, Z.; Hiripi, L.; Bodrogi, L. The Creation of a Multiallele Knockout Genotype in Rabbit Using CRISPR/Cas9 and Its Application in Translational Medicine. Appl. Sci. 2020, 10, 8508. https://0-doi-org.brum.beds.ac.uk/10.3390/app10238508

AMA Style

Pintér T, Geiszt M, Petheő GL, Mihálffy M, Skoda G, Lipták N, Kerekes A, Bősze Z, Hiripi L, Bodrogi L. The Creation of a Multiallele Knockout Genotype in Rabbit Using CRISPR/Cas9 and Its Application in Translational Medicine. Applied Sciences. 2020; 10(23):8508. https://0-doi-org.brum.beds.ac.uk/10.3390/app10238508

Chicago/Turabian Style

Pintér, Tímea, Miklós Geiszt, Gábor L. Petheő, Máté Mihálffy, Gabriella Skoda, Nándor Lipták, Andrea Kerekes, Zsuzsanna Bősze, László Hiripi, and Lilla Bodrogi. 2020. "The Creation of a Multiallele Knockout Genotype in Rabbit Using CRISPR/Cas9 and Its Application in Translational Medicine" Applied Sciences 10, no. 23: 8508. https://0-doi-org.brum.beds.ac.uk/10.3390/app10238508

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop